MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dystonia: Treatment"

  • 2022 International Congress

    Two cases of severe generalized dystonia in IRF2BPL and response to treatment

    M. Hull, M. Parnes (Houston, USA)

    Objective: We describe two patients who presented with progressive, generalized dystonia and associated neurodevelopmental regression in early childhood found to have pathogenic variants in IRF2BPL.…
  • MDS Virtual Congress 2021

    COMPARISON OF ELECTROPHYSIOLOGIC AND ULTRASOUND GUIDANCE FOR ONABOTULINUM TOXIN-A INJECTIONS IN FOCAL UPPER EXTREMITY SPASTICITY AND DYSTONIA

    C. Lungu, A. Nmashie, MC. George, T. Wu, S. Shin, B. Karp, E. Considine, W. Tse, S. Frucht, C. Wu, V. Koo, G. Norato, K. Alter, M. Hallet, DM. Simpson ()

    Objective: To investigate two targeting techniques for onabotulinum toxin-A (BoNT) injection for the treatment of focal hand dystonia and upper limb spasticity: guidance with electrical…
  • MDS Virtual Congress 2021

    Effects of Gandouling Tablets on the Muscle tone and stiffness of patients with Wilson’s disease: a randomized, double-blind, placebo-controlled study

    W. Hao (Hefei, China)

    Objective: To analyze the effects of Gandouling tablets(GDL) on the tone and stiffness of the biceps brachii muscle in Wilson’s disease (WD) patients, and the correlation between…
  • MDS Virtual Congress 2021

    A novel ANO3 variant associated with generalized dystonia in an elderly woman

    A. Boddu, H. Williams, H. Walker (Birmingham, USA)

    Objective: To report a case of dystonia that adds to the growing body of literature regarding the genotypic variants associated with the ANO3 gene implicated…
  • MDS Virtual Congress 2021

    Neuroinflammation and Anti-Psychotic Drugs Induced Hyperkinesia or Dystonia in Treatment of Organic Brain Psychoses and Schizophrenia

    D. Labunskiy, S. Kiryukhina, V. Kolmykov, E. Govsh, D. Baranov, E. Razgadova (Saransk, Russian Federation)

    Objective: Our study goal was evaluation of neuroinflammatory processes in patients with psychoses received  anti-psychotic medications and developed hyperkinesia or dystonia symptoms. Evaluation of pro-inflammatory…
  • MDS Virtual Congress 2021

    GPi-DBS for KMT2B-associated dystonia: systematic review and meta-analysis

    A. Saini (New Deelhi, India)

    Objective: To determine the efficacy of pallidal stimulation and GPi-DBS in KMT2B-associated dystonia. Background: Early evidence suggests good response to pallidal stimulation in KMT2B dystonia,…
  • MDS Virtual Congress 2021

    Impact of Disease Severity on Presentation Subtype and OnabotulinumtoxinA Utilization in Patients with Cervical Dystonia: Results from the CD PROBE Completer Population

    P. Agarwal, R. Barbano, H. Moore, M. Schwartz, A. Zuzek, A. Patel (Kirkland, USA)

    Objective: Examine the impact of cervical dystonia (CD) severity on presentation subtype and onabotulinumtoxinA utilization in the completer population from the CD PROBE study. Background:…
  • MDS Virtual Congress 2021

    Deep Brain Stimulation in Confirmed Genetic Dystonias: A Comprehensive Review

    H. Sarva, F. Rodriguez-Porcel, S. Barkan, E. Gatto, P. Garcia Ruiz (New York, USA)

    Objective: Review DBS benefit in genetically confirmed dystonias. Background: Deep brain stimulation (DBS) is an established option for genetic dystonias such as DYT-1. While literature…
  • MDS Virtual Congress 2021

    A real-life study of Medical Cannabis effect on adults with dystonia

    S. Anis, A. Faust-Socher, D. Sverdlov, N. Hezi, N. Giladi, T. Gurevich (Tel Aviv, Israel)

    Objective: To assess the effect of Medical Cannabis (MC) on patients with dystonia. Background: MC has been suggested to treat involuntary contractions of muscles in…
  • MDS Virtual Congress 2021

    Exploring Local Field Potential changes in Dystonic Camptocormia.

    M. Chua, C. Harrington, S. Stanslaski, M. Hayes, G. Cosgrove, T. Herrington (Boston, USA)

    Objective: To describe a novel technology for detection of local field potentials in bilateral GPi-DBS to identify local field potential biomarker changes in dystonic camptocormia.…
  • « Previous Page
  • 1
  • …
  • 16
  • 17
  • 18
  • 19
  • 20
  • …
  • 39
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley